Commercialization: Page 72

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    SALES, MARKETING, AND R&D TRENDS AFFECTING THE HEALTHCARE INDUSTRY NestEggz Survey Suggests PATIENTS WHO SAVE ON PRESCRIPTIONS TAKE THEIR MEDICATION Almost 90% of cholesterol patients enrolled in NestEggz were found to take their medication daily, almost double the national average.NestEggz,a...

    By PharmaVoice Team • Jan. 14, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    For Art's Sake

    Catchy, creative, and memorable are three words to describe this month’s selection of standout creative executions. Two of the ad campaigns, Viagra and Glucotrol XL, were executed by Cline, Davis &Mann on behalf of client Pfizer Inc. The first of the ads was cre ated for the launch of Viagra....

    By PharmaVoice Team • Jan. 14, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Outlet

    For the first time since the Food and Drug Administration lessened restrictions on direct to consumer pharmaceutical advertisements in 1996, there is a significant slowing in direct to consumer advertising expenditures. From 1996 to 2000, directtoconsumer advertising spending grew more than three...

    By Susan Hempstead • Jan. 14, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's on Your Mind: Opinions

    The economy In my opinion, the biggest impact on the industry has been the fallout from the economic downturn. A climate of near paralysis has seized much of the industry and I don’t expect that climate to change much until well into 2003. The uncertainty of the timing of the eco nomic turnaround...

    By PharmaVoice Team • Jan. 14, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise your voice: Letters

    Turn up the volume Each month, our team looks forward to what’s inside the next issue of PharmaVoice. It’s fresh, uncanny in its timeliness, and always relevant. (Like us.) Evenhanded panels of industry experts help us weigh the issues that are going to matter, and the statistics are so fresh tha...

    By PharmaVoice Team • Jan. 14, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    PharmaVOICE A product lives on a shelf. A brand lives in the mind of the consumer . The challenge, according to industry experts, is making an emotional connection between the two. A brand goes beyond the rational; a brand is the promise the product offers the customer or stakeholder, whether tha...

    By PharmaVoice Team • Jan. 14, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Practical Medicine:

    Diagnosing the condition DERMAN. Insurance and reimbursement are two big challenges. Part of the problem is that reimbursement rates have dropped, thus physicians need to see more patients, more efficiently, in the same period of time to cover overhead. This is true even in an academic environmen...

    By PharmaVoice Team • Jan. 14, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Xyrem: Awakenings

    PharmaVOICE approved for treating cataplexy. Of the esti mated 140,000 Americans who suffer from narcolepsy, between 60% and 90% experience cataplexy. Orphan Medical Inc. developed Xyrem under the FDA’s Orphan Drug Act of 1983, which provides market exclusivity to companies that develop products ...

    By PharmaVoice Team • Jan. 14, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Brand-cycle management

    By 2005, many multibillion dollar drugs will come off patent, including blockbuster drugs such as Claritin, Viagra, Glucophage, and Prilosec (see chart on page 51). The finan cial incentives for prolonging the life of these brands are enormous. Last year, Claritin earned almost $2 billion in sale...

    By PharmaVoice Team • Jan. 14, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma POOL Dr. Jack GOLDSTEIN Chiron Names Blood Testing Division President Chiron Corp. has named Jack Goldstein, Ph.D., president of Chi ron’s blood testing division. Dr. Goldstein is responsible for the commercial operations of Chiron’s blood testing business, based in Emeryville, Calif. He a...

    By PharmaVoice Team • Jan. 13, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES The Rosetta Luminator system, a clientserver bioinformatics system for storing and analyzing microarray data, has been launched by Rosetta Biosoftware and Agilent Technologies Inc. The geneexpression data analysis solution was deve...

    By PharmaVoice Team • Jan. 13, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES TrialCard’s patented “IA Technology” is designed to replace prepackaged drug samples. By using a device similar to a credit card that can be activated and deactivated, manufacturers can distribute their samples through pharmacies, and can im...

    By PharmaVoice Team • Jan. 13, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    NEUROTHERAPEUTICS AND GENE AMPLIFICATION Markets Predicted to Grow Unmet need and ballooning incidence are expected to create huge market potential in neuro logical drugs,according to a study by Kalorama Infor mation. The world market stands at $70 billion, but steady growth in demand and product...

    By PharmaVoice Team • Jan. 13, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    For Art's Sake

    CREATIVE review There are many times in healthcare advertising when humor is not appropriate,but for every ad that misuses humor there are hundreds of others that have wasted the opportunity to elicit a chuckle or to add a touch of irony. Humor is one of the most underutilized tools that we have....

    By PharmaVoice Team • Jan. 13, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharma Outlet

    Fewer new drug approvals, the political spotlight on the pharmaceutical industry, promotional budget cutbacks. What else can go wrong in the healthcare communications industry? Pitted against their more endowed competitors, small agencies may be wellsuited to survive in today’s adverse environmen...

    By Rico Viray • Jan. 13, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise Your Voice: Letters

    Missed opportunity I applaud the fact that PharmaVOICE has highlighted the importance of the new PhRMA Voluntary Marketing Code, but I would be remiss if I didn’t ask: “Where in this article is the discussion about the benefit of the new code to the patient?” In reading through this 11 page artic...

    By PharmaVoice Team • Jan. 13, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski CONTRIBUTING EDITORS Virginia Kirk Denise Myshko Elisabeth Pena Kim Ribbink Alex Robinson Lynda Sears Copyright 2002 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Two, Numb...

    By Taren Grom • Jan. 13, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Value of Innovation

    BY ALEX ROBINSON Let’s stop complaining about spending on prescription drugs,” Alan Holmer, president of the Phar maceutical Research and Manufacturers of Ameri ca (PhRMA) told an audience in April. “In fact, let’s hope that prescription drug spending goes up — not down.” Critics are quick to poi...

    By Alex Robinson • Jan. 11, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma POOL Margaret M.FORAN Chuck HARDWICK Pat KELLY Ian READ Pfizer Names Presidents for U.S., European Pharmaceuticals Businesses,Head of Corporate Affairs, and Corporate Secretary Pat Kelly and Ian Read have been appointed presidents responsible for the U.S. and European pharmaceuticals busin...

    By PharmaVoice Team • Jan. 11, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    NEW ELECTRONIC AND WEB BASED APPLICATIONS, SITES, AND TECHNOLOGIES MDchoice.com Inc. has unveiled a new marketing platform that allows hospitals, clinics, and physician groups to offer their own private label online healthcare information services. The platform offers health information ranging f...

    By PharmaVoice Team • Jan. 11, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    NEW HEALTHCARE RELATED PRODUCTS, SERVICES, AND COMPANIES Dorland Sweeney Jones Health Communications is reaffirming its position as a leader in global health communications and creating a power brand by simplifying its name and organizational structure. The agency has returned to its original nam...

    By PharmaVoice Team • Jan. 11, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Teams and effective practices that drive corporate growth. “Successful new product plan ning efforts realize that analytical teamstaffing efforts are essential to today’s blockbuster products,” says Paul Meade, VP at Best Prac tices. “Teams that have well rounded members who can bring a combinati...

    By PharmaVoice Team • Jan. 11, 2010
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Incentive Compensation

    As the new environment of pharma sales shifts to more specialized and consumer-centric approaches, the industry will need to respond to ­adequately compensate and incentivize its sales teams. Our experts say prescription numbers will remain the predominant measurement for sales rep performance in...

    By Robin Robinson • Dec. 29, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Contents

    In Every Issue 3 Letter from the Editor 8 Upfront A brief review of industry news at press time 36 Pharma Trax Sales, marketing, and R&D trends from industry analysts 40 What’s New New healthcare-related products, services, and companies 42 E-Media New electronic and Web-based applications, s...

    By PharmaVoice Team • Dec. 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Pharmaceutical Manufacturing Under Scrutiny

    Across the board — from labeling and marketing, to clinical trials, to manufacturing processes — regulators are becoming more active in safeguarding the public and ensuring the safety of pharmaceuticals. Even before the news broke regarding Genzyme Corp.’s recent virus and contamination problems ...

    By PharmaVoice Team • Dec. 28, 2009